Literature DB >> 9124944

Candida pericarditis: clinical profile and treatment.

R Rabinovici1, D Szewczyk, P Ovadia, J R Greenspan, J J Sivalingam.   

Abstract

BACKGROUND: Candida pericarditis is a rare medical and surgical emergency which, unless treated, leads to impaired cardiac function and death. To facilitate early diagnosis, the clinical features of this condition should be identified.
METHODS: Twenty-five cases of Candida pericarditis reported in the last 30 years along with 1 new case were reviewed with regard to demographics, precipitating factors, diagnosis, treatment, and outcome.
RESULTS: The syndrome occurred in immunocompromised (73%), antibiotic-treated (62%), or postpericardiotomy (54%) patients. The clinical presentation was frequently subtle and nonspecific. Nevertheless, unexplained fever, an increasing cardiac shadow on chest roentgenogram, or the development of cardiac tamponade may be suggestive. Positive culture for Candida in pericardial fluid or histologic evidence of yeast forms in pericardial tissue establishes the diagnosis. A combination of pericardiocentesis followed by operative drainage and antifungal agents is the usual treatment. Untreated, Candida pericarditis is 100% lethal, whereas prompt diagnosis and treatment lead to cure (mean follow-up, 19 months).
CONCLUSIONS: Fever and evolving cardiac tamponade in immunocompromised or postpericardiotomy patients may be suggestive of Candida pericarditis; the presence of organisms in pericardial fluid is diagnostic. Pericardiocentesis followed by operative drainage and antifungal agents appears to be the treatment that is most likely to be curative.

Entities:  

Mesh:

Year:  1997        PMID: 9124944     DOI: 10.1016/s0003-4975(97)00086-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 2.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Epidemiology and treatment approaches in management of invasive fungal infections.

Authors:  Jane Kriengkauykiat; James I Ito; Sanjeet S Dadwal
Journal:  Clin Epidemiol       Date:  2011-05-19       Impact factor: 4.790

4.  Purulent Pericarditis with Cardiac Tamponade Secondary to Candida Albicans after Total Parenteral Nutrition: A Case Report.

Authors:  Ömer Kertmen; Gökhan Gök; Murat Akçay
Journal:  J Tehran Heart Cent       Date:  2020-07

5.  Candida pericarditis presenting with cardiac tamponade and multiple organ failure after combined damage control thoracotomy and laparotomy with splenectomy in a trauma patient: Case report and review of literature.

Authors:  R A Siller; J J Skubic; J L Almeda; J F Villarreal; A E Kaplan
Journal:  Trauma Case Rep       Date:  2021-12-08

6.  Storage Artifact Masquerading as Yeast: Presenting a Diagnostic Pitfall.

Authors:  Elena M Fenu; Tawfeq Naal; Elizabeth Palavecino
Journal:  Case Rep Pathol       Date:  2022-10-08

7.  Cardiac tamponade, an unusual and fatal complication of esophagus dilatation for benign stenosis: a case report.

Authors:  Wendela L Greven; Nicole Kooij; Herman M Peters; Joost Kardux; Peter E Spronk
Journal:  Cases J       Date:  2008-12-24

Review 8.  Evaluation of human body fluids for the diagnosis of fungal infections.

Authors:  Parisa Badiee
Journal:  Biomed Res Int       Date:  2013-08-01       Impact factor: 3.411

9.  A case report of purulent pericarditis caused by Candida albicans: Delayed complication forty-years after esophageal surgery.

Authors:  Joowhan Sung; Irving Enrique Perez; Addi Feinstein; David Kidd Stein
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.